Bone mineral density is not reduced in HIV-infected Caucasian men treated with highly active antiretroviral therapy

Clinical Endocrinology

Volumn 65, Issue 2, 2006, Pages 191-197

  Bolland, Mark J ^a   Grey, Andrew B ^a   Horne, Anne M ^a   Briggs, Simon E ^b   Thomas, Mark G ^a,b   Ellis Pegler, Rod B ^a,b   Woodhouse, Andrew F ^b   Gamble, Greg D ^a   Reid, Ian R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; NON NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY WEIGHT; BONE DENSITY; CAUCASIAN; CONTROLLED STUDY; DISEASE DURATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NONHUMAN; PREDICTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; UNSPECIFIED SIDE EFFECT;

ANALYSIS OF VARIANCE; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY WEIGHT; BONE DENSITY; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CONFOUNDING FACTORS (EPIDEMIOLOGY); CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; HIP; HIV INFECTIONS; HUMANS; LUMBAR VERTEBRAE; MALE;

EID: 33746080475     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02572.x     Document Type: Article

References (40)

1. Cascade Collaboration (2000) Changes in the uptake of antiretroviral therapy and survival in people with known duration of HIV infection in Europe: results from CASCADE. HIV Medicine, 1, 224-231.
2. Detels, R., Munoz, A., McFarlane, G., Kingsley, L.A., Margolick, J.B., Giorgi, J., Schrager, L.K. & Phair, J.P. (1998) Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators. Journal of the American Medical Association, 280, 1497-1503.
3. Brechtl, J.R., Breitbart, W., Galietta, M., Krivo, S. & Rosenfeld, B. (2001) The use of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection: impact on medical, palliative care, and quality of life outcomes. Journal of Pain and Symptom Management, 21, 41-51.
4. Mole, L., Ockrim, K. & Holodniy, M. (1999) Decreased medical expenditures for care of HIV-seropositive patients. The impact of highly active antiretroviral therapy at a US Veterans Affairs Medical Center. Pharmacoeconomics, 16, 307-315.
5. Revicki, D.A., Moyle, G., Stellbrink, H.J. & Barker, C. (1999) Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter. PISCES (SV14604) Study Group. AIDS, 13, 851-858.
6. Monier, P.L. & Wilcox, R. (2004) Metabolic complications associated with the use of highly active antiretroviral therapy in HIV-1-infected adults. American Journal of the Medical Sciences, 328, 48-56.
7. Tebas, P., Powderly, W.G., Claxton, S., Marin, D., Tantisiriwat, W., Teitelbaum, S.L. & Yarasheski, K.E. (2000) Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS, 14, F63-F67.
8. Carr, A., Miller, J., Eisman, J.A. & Cooper, D.A. (2001) Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy. AIDS, 15, 703-709.
9. Fairfield, W.P., Finkelstein, J.S., Klibanski, A. & Grinspoon, S.K. (2001) Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome. Journal of Clinical Endocrinology and Metabolism, 86, 2020-2026.
10. Huang, J.S., Rietschel, P., Hadigan, C.M., Rosenthal, D.I. & Grinspoon, S. (2001) Increased abdominal visceral fat is associated with reduced bone density in HIV-infected men with lipodystrophy. AIDS, 15, 975-982.
11. Huang, J.S., Wilkie, S.J., Sullivan, M.P. & Grinspoon, S. (2001) Reduced bone density in androgen-deficient women with acquired immune deficiency syndrome wasting. Journal of Clinical Endocrinology and Metabolism, 86, 3533-3539.
12. Knobel, H., Guelar, A., Vallecillo, G., Nogues, X. & Diez, A. (2001) Osteopenia in HIV-infected patients: is it the disease or is it the treatment? AIDS, 15, 807-808.
13. Lawal, A., Engelson, E.S., Wang, J., Heymsfield, S.B. & Kotler, D.P. (2001) Equivalent osteopenia in HIV-infected individuals studied before and during the era of highly active antiretroviral therapy. AIDS, 15, 278-280.
14. Moore, A.L., Vashisht, A., Sabin, C.A., Mocroft, A., Madge, S., Phillips, A.N., Studd, J.W. & Johnson, M.A. (2001) Reduced bone mineral density in HIV-positive individuals. AIDS, 15, 1731-1733.
15. Nolan, D., Upton, R., McKinnon, E., John, M., James, I., Adler, B., Roff, G., Vasikaran, S. & Mallal, S. (2001) Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir. AIDS, 15, 1275-1280.
16. Gold, J., Pocock, N. & Li, Y. (2002) Bone mineral density abnormalities in patients with HIV infection. Journal of Acquired Immune Deficiency Syndromes, 30, 131-132.
17. Loiseau-Peres, S., Delaunay, C., Poupon, S., Lespessailles, E., Ballouche, N., Arsac, P. & Benhamou, C.L. (2002) Osteopenia in patients infected by the human immunodeficiency virus. A case control study. Joint Bone Spine, 69, 482-485.
18. Bruera, D., Luna, N., David, D.O., Bergoglio, L.M. & Zamudio, J. (2003) Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy. AIDS, 17, 1917-1923.
19. Fernandez-Rivera, J., Garcia, R., Lozano, F., Macias, J., Garcia-Garcia, J.A., Mira, J.A., Corzo, J.E., Gomez-Mateos, J., Rueda, A., Sanchez-Burson, J. & Pineda, J.A. (2003) Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients. HIV Clinical Trials, 4, 337-346.
20. Mondy, K., Yarasheski, K., Powderly, W.G., Whyte, M., Claxton, S., DeMarco, D., Hoffmann, M. & Tebas, P. (2003) Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals. Clinical Infection and Disease, 36, 482-490.
21. Vescini, F., Borderi, M., Buffa, A., Sinicropi, G., Tampellini, L., Chiodo, F. & Caudarella, R. (2003) Bone mass in HIV-infected patients: focus on the role of therapy and sex. Journal of Acquired Immune Deficiency Syndromes, 33, 405-407.
22. Amiel, C., Ostertag, A., Slama, L., Baudoin, C., N'Guyen, T., Lajeunie, E., Neit-Ngeilh, L., Rozenbaum, W. & De Vernejoul, M.C. (2004) BMD is reduced in HIV-infected men irrespective of treatment. Journal of Bone Mineral Research, 19, 402-409.
23. Brown, T.T., Ruppe, M.D., Kassner, R., Kumar, P., Kehoe, T., Dobs, A.S. & Timpone, J. (2004) Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia. Journal of Clinical Endocrinology and Metabolism, 89, 1200-1206.
24. Dolan, S.E., Huang, J.S., Killilea, K.M., Sullivan, M.P., Aliabadi, N. & Grinspoon, S. (2004) Reduced bone density in HIV-infected women. AIDS, 18, 475-483.
25. Landonio, S., Quirino, T., Bonfanti, P., Gabris, A., Boccassini, L., Gulisano, C., Vulpio, L., Ricci, E., Carrabba, M. & Vigevani, G.M. (2004) Osteopenia and osteoporosis in HIV+ patients, untreated or receiving HAART. Biomedicine and Pharmacotherapy, 58, 505-508.
26. Madeddu, G., Spanu, A., Solinas, P., Calia, G.M., Lovigu, C., Chessa, F., Mannazzu, M., Falchi, A. & Mura, M.S. (2004) Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy. Quarterly Journal of Nuclear Medicine and Molecular Imaging, 48, 39-48.
27. Thomas, J. & Doherty, S.M. (2003) HIV infection - a risk factor for osteoporosis. Journal of Acquired Immune Deficiency Syndromes, 33, 281-291.
28. Reid, I.R. (2002) Relationships among body mass, its components, and bone. Bone, 31, 547-555.
29. Ward, K.D. & Klesges, R.C. (2001) A meta-analysis of the effects of cigarette smoking on bone mineral density. Calcified Tissue International, 68, 259-270.
30. Mills, G., Yardley, A.M., Thomas, M., Blackmore, T., Pithie, A., Schroeder, B. & Dickson, N. (2002) New Zealand's HIV infected population under active follow-up during 2000. New Zealand Medical Journal, 115, 173-176.
31. Wang, M.W.-H., Wei, S., Faccio, R., Takeshita, S., Tebas, P., Powderly, W.G., Teitelbaum, S.L. & Ross, F.P. (2004) The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling. Journal of Clinical Investigation, 114, 206-213.
32. Jain, R.G. & Lenhard, J.M. (2002) Select HIV protease inhibitors alter bone and fat metabolism ex vivo. Journal ofBiological Chemistry, 277, 19247-19250.
33. Hannan, M.T., Felson, D.T., Dawson-Hughes, B., Tucker, K.L., Cupples, L.A., Wilson, P.W. & Kiel, D.P. (2000) Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. Journal of Bone Mineral Research, 15, 710-720.
34. Wu, F., Ames, R., Clearwater, J., Evans, M.C., Gamble, G. & Reid, I.R. (2002) Prospective 10-year study of the determinants of bone density and bone loss in normal postmenopausal women, including the effect of hormone replacement therapy. Clinical Endocrinology, 56, 703-711.
35. Cirelli, A., Cirelli, G., Balsamo, G., Masciangelo, R., Stasolla, A. & Marini, M. (2003) Body habitus changes, metabolic abnormalities, osteopenia and cardiovascular risk in patients treated for human immunodeficiency virus infection. Annali Italiani di Medicina Interna, 18, 238-245.
36. Tebas, P., Yarasheski, K., Henry, K., Claxton, S., Kane, E., Bordenave, B., Klebert, M. & Powderly, W.G. (2004) Evaluation of the virological and metabolic effects of switching protease inhibitor combination antiretroviral therapy to nevirapine-based therapy for the treatment of HIV infection. AIDS Research and Human Retroviruses, 20, 589-594.
37. Istvan, J.A., Cunningham, T.W. & Garfinkel, L. (1992) Cigarette smoking and body weight in the Cancer Prevention Study I. International Journal of Epidemiology, 21, 849-853.
38. Blanchard, R. & Bogaert, A.F. (1996) Biodemographic comparisons of homosexual and heterosexual men in the Kinsey Interview Data. Archives of Sexual Behavior, 25, 551-579.
39. Beren, S.E., Hayden, H.A., Wilfley, D.E. & Grilo, C.M. (1996) The influence of sexual orientation on body dissatisfaction in adult men and women. International Journal of Eating Disorders, 20, 135-141.
40. Ryan, H., Wortley, P.M., Easton, A., Pederson, L. & Greenwood, G. (2001) Smoking among lesbians, gays, and bisexuals: a review of the literature. American Journal of Preventive Medicine, 21, 142-149.